Value investing remains one of the most time-tested approaches in the financial world, rooted in the principle of buying assets for less than they are worth. The strategy, famously championed by Benjamin Graham and later refined by Warren Buffett and Charlie Munger, revolves around identifying companies whose market price sits below their intrinsic value. The challenge lies not just in finding a low stock price, but in confirming that the underlying business is fundamentally sound. This means looking beyond just a cheap price-to-earnings ratio and digging into profitability, financial health, and growth potential to avoid the so-called “value trap.” The “Decent Value” screen we used applies this logic systematically, filtering for stocks that offer a compelling valuation while maintaining solid fundamentals across the board.
CF INDUSTRIES HOLDINGS INC (NYSE:CF) recently emerged from this screen, and the numbers suggest it warrants a closer look. As a leading manufacturer and distributor of nitrogen fertilizers, the company operates in a cyclical but essential industry. At first glance, the valuation metrics are striking, but the real story is in how they pair with the company’s profitability and financial strength.
Valuation Metrics
The core of any value investment thesis is the price you pay relative to what you get. For CF, the valuation picture is compelling. The company currently trades at a Price/Earnings (P/E) ratio of 9.66, which is significantly cheaper than 95.24% of its peers in the Chemicals industry. To put that in perspective, the industry average P/E sits at roughly 40, while the S&P 500 average is near 26.6. Even looking forward, the Price/Forward Earnings ratio of 9.26 indicates similar cheapness, undercutting the vast majority of competitors and the broader market.
Other valuation multiples reinforce this view:
- Enterprise Value to EBITDA (EV/EBITDA): Cheaper than 96.43% of industry peers.
- Price/Free Cash Flow (P/FCF): Cheaper than 91.67% of industry peers.
This kind of discount is exactly what value investors look for—a stock that the market has seemingly overlooked or undervalued relative to its earnings power. The low PEG Ratio (based on NY growth estimates) further suggests that the current price does not fully reflect the company's growth trajectory, making it a potentially attractive entry point.
Profitability
A cheap stock is only a bargain if the underlying business is profitable and well-run. Here, CF scores a perfect 10 out of 10 on the ChartMill Profitability rating. This is not a company scraping by on thin margins, it is an earnings powerhouse.
Key profitability highlights include:
- Return on Equity (ROE): 32.91%, outperforming 97.62% of industry peers.
- Return on Invested Capital (ROIC): 15.40%, which outranks 97.62% of peers and has improved from its 3-year average of 13.07%, indicating increasing efficiency.
- Profit Margin: 23.73%, placing it in the top 1% of the industry—a truly elite figure.
- Operating Margin: 34.58%, better than 96.43% of competitors.
- Gross Margin: 39.13%, outperforming 82.14% of peers.
These margins have been improving over the last couple of years, suggesting operational discipline and pricing power. For a value investor, this profitability is a critical buffer. It means the company generates significant cash flow and can weather economic downturns better than weaker competitors, reducing the risk of a value trap.
Health
Financial strength is the bedrock of a value investment. A company with high debt or liquidity issues can quickly turn a discount into a disaster. CF scores a solid 8 out of 10 on the Health rating, with particularly strong liquidity.
Consider the following:
- Current Ratio: 3.54, higher than 89.29% of industry peers, indicating ample short-term assets to cover obligations.
- Quick Ratio: 3.15, outperforming 91.67% of peers, showing even more stringent liquidity coverage.
- Debt to Free Cash Flow: A low 1.64, meaning the company could theoretically pay off all its debt in less than two years using free cash flow. This is better than 95.24% of competitors.
- Debt to Equity: 0.60, which is reasonable and manageable.
- Share Count: The company has reduced its outstanding shares over the past year and compared to five years ago, which is a shareholder-friendly move that boosts per-share metrics.
While the Altman-Z score of 2.73 is not spectacular, it indicates only limited bankruptcy risk. The overall picture is one of a company with a clean balance sheet and low leverage, which reduces the risk profile for a long-term value hold.
Growth
No discussion of value is complete without growth. Even a cheap stock needs some forward momentum to close the gap between market price and intrinsic value. CF scores a 5 out of 10 on Growth, with a clear story in the numbers.
Past performance is strong:
- Earnings Per Share (EPS) Growth (last year): 43.86%
- Average EPS Growth (last 5 years): 45.21% per year
- Revenue Growth (last year): 20.85%
- Average Revenue Growth (historically): 11.43% per year
These are impressive figures, but the future outlook is more tempered. Analysts expect EPS to decline by about 1.55% on average over the next few years, and revenue to shrink slightly by 0.04%. This is likely tied to the cyclical nature of fertilizer prices and global agricultural demand. For a value investor, this is not necessarily a deal-breaker. The key is that the current valuation already prices in this deceleration. If the company can maintain its profitability and financial health through the cycle, it remains a strong candidate for long-term appreciation.
Summary and Conclusion
CF Industries presents a textbook case for a disciplined value investor: a company with elite profitability, a fortress-like balance sheet, and a valuation that is deeply discounted relative to both its peers and the broader market. The growth outlook is cautious, but the low price already accounts for that risk. The ChartMill Fundamental Analysis Report provides a full breakdown of these ratings, confirming the synergy between cheap valuation and operational strength.
If this approach resonates with you, the screen used to find CF is accessible and repeatable. You can explore more stocks that exhibit a solid value profile with decent fundamentals by checking out the Decent Value Screen for a broader list of candidates that meet these criteria.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Always conduct your own research or consult with a qualified financial advisor before making any investment decisions.
Read full article here »
View the Zacks #1 Rank List
CF Industries Holdings Inc (NYSE:CF): A Deep Value Play with Elite Profitability and Balance Sheet Strength
Value investing remains one of the most time-tested approaches in the financial world, rooted in the principle of buying assets for less than they are worth. The strategy, famously championed by Benjamin Graham and later refined by Warren Buffett and Charlie Munger, revolves around identifying companies whose market price sits below their intrinsic value. The challenge lies not just in finding a low stock price, but in confirming that the underlying business is fundamentally sound. This means looking beyond just a cheap price-to-earnings ratio and digging into profitability, financial health, and growth potential to avoid the so-called “value trap.” The “Decent Value” screen we used applies this logic systematically, filtering for stocks that offer a compelling valuation while maintaining solid fundamentals across the board.
CF INDUSTRIES HOLDINGS INC (NYSE:CF) recently emerged from this screen, and the numbers suggest it warrants a closer look. As a leading manufacturer and distributor of nitrogen fertilizers, the company operates in a cyclical but essential industry. At first glance, the valuation metrics are striking, but the real story is in how they pair with the company’s profitability and financial strength.
Valuation Metrics
The core of any value investment thesis is the price you pay relative to what you get. For CF, the valuation picture is compelling. The company currently trades at a Price/Earnings (P/E) ratio of 9.66, which is significantly cheaper than 95.24% of its peers in the Chemicals industry. To put that in perspective, the industry average P/E sits at roughly 40, while the S&P 500 average is near 26.6. Even looking forward, the Price/Forward Earnings ratio of 9.26 indicates similar cheapness, undercutting the vast majority of competitors and the broader market.
Other valuation multiples reinforce this view:
This kind of discount is exactly what value investors look for—a stock that the market has seemingly overlooked or undervalued relative to its earnings power. The low PEG Ratio (based on NY growth estimates) further suggests that the current price does not fully reflect the company's growth trajectory, making it a potentially attractive entry point.
Profitability
A cheap stock is only a bargain if the underlying business is profitable and well-run. Here, CF scores a perfect 10 out of 10 on the ChartMill Profitability rating. This is not a company scraping by on thin margins, it is an earnings powerhouse.
Key profitability highlights include:
These margins have been improving over the last couple of years, suggesting operational discipline and pricing power. For a value investor, this profitability is a critical buffer. It means the company generates significant cash flow and can weather economic downturns better than weaker competitors, reducing the risk of a value trap.
Health
Financial strength is the bedrock of a value investment. A company with high debt or liquidity issues can quickly turn a discount into a disaster. CF scores a solid 8 out of 10 on the Health rating, with particularly strong liquidity.
Consider the following:
While the Altman-Z score of 2.73 is not spectacular, it indicates only limited bankruptcy risk. The overall picture is one of a company with a clean balance sheet and low leverage, which reduces the risk profile for a long-term value hold.
Growth
No discussion of value is complete without growth. Even a cheap stock needs some forward momentum to close the gap between market price and intrinsic value. CF scores a 5 out of 10 on Growth, with a clear story in the numbers.
Past performance is strong:
These are impressive figures, but the future outlook is more tempered. Analysts expect EPS to decline by about 1.55% on average over the next few years, and revenue to shrink slightly by 0.04%. This is likely tied to the cyclical nature of fertilizer prices and global agricultural demand. For a value investor, this is not necessarily a deal-breaker. The key is that the current valuation already prices in this deceleration. If the company can maintain its profitability and financial health through the cycle, it remains a strong candidate for long-term appreciation.
Summary and Conclusion
CF Industries presents a textbook case for a disciplined value investor: a company with elite profitability, a fortress-like balance sheet, and a valuation that is deeply discounted relative to both its peers and the broader market. The growth outlook is cautious, but the low price already accounts for that risk. The ChartMill Fundamental Analysis Report provides a full breakdown of these ratings, confirming the synergy between cheap valuation and operational strength.
If this approach resonates with you, the screen used to find CF is accessible and repeatable. You can explore more stocks that exhibit a solid value profile with decent fundamentals by checking out the Decent Value Screen for a broader list of candidates that meet these criteria.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Always conduct your own research or consult with a qualified financial advisor before making any investment decisions.
Read full article here »